| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/25/2006 | US7033592 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 04/25/2006 | US7033591 use of a membrane fraction of gram-negative bacteria such as Klebsiella pnemoniae comprising proteoglycans in combination with anticancer treatment for immunostimulant and/or inducing an antitumor immune response in mammals including humans |
| 04/25/2006 | US7033590 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 04/25/2006 | US7033589 γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/25/2006 | US7033572 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/25/2006 | CA2353520C Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 04/20/2006 | WO2006042240A2 Immunotherapy of autoimmune disorders |
| 04/20/2006 | WO2006042237A2 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 04/20/2006 | WO2006042177A2 Mature dendritic cell compositions and methods for culturing same |
| 04/20/2006 | WO2006042158A2 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | WO2006042062A2 Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases |
| 04/20/2006 | WO2006042027A2 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 04/20/2006 | WO2006041970A2 Treatment of respiratory syncytial virus (rsv) infection |
| 04/20/2006 | WO2006041934A2 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | WO2006041933A2 Improved vaccines |
| 04/20/2006 | WO2006041906A2 Methods and compositions for immunizing against pseudomonas infection |
| 04/20/2006 | WO2006041890A2 Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy |
| 04/20/2006 | WO2006041641A2 Therapeutic agents with decreased toxicity |
| 04/20/2006 | WO2006041048A1 Liver regeneration/repair controlling agent |
| 04/20/2006 | WO2006040481A2 Method for diagnosing and treating crohn's disease |
| 04/20/2006 | WO2006040334A1 Malaria prime/boost vaccines |
| 04/20/2006 | WO2006040322A1 Binding molecules for treatment and detection of cancer |
| 04/20/2006 | WO2006040163A1 Monoclonal antibody against frizzled receptors |
| 04/20/2006 | WO2006040076A2 Vaccination adjuvants pam3cys, poly(i:c), imiquimod, loxoribine, r-848 and cpg-dna together with mhc i or mhc ii epitopes |
| 04/20/2006 | WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 04/20/2006 | WO2006014903A3 Compositions and methods of use for adam12 antagonists in treating disease |
| 04/20/2006 | WO2006004749A3 Compositions and methods for treating neurological disorders |
| 04/20/2006 | WO2005118802A3 Targeting pseudotyped retroviral vectors |
| 04/20/2006 | WO2005112969A3 Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors |
| 04/20/2006 | WO2005111077A3 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 04/20/2006 | WO2005097185A3 Irta-5 antibodies and their uses |
| 04/20/2006 | WO2005097183A3 Treatment of diseases |
| 04/20/2006 | WO2005092378A3 Anti-vglut glutamate transporter antibodies for use in pain therapy |
| 04/20/2006 | WO2005089315A3 Methods and compositions related to skcg-1, a tumor suppressor gene |
| 04/20/2006 | WO2005085867A3 Screening method for emulators of neural activity and digestive system using gpr35 |
| 04/20/2006 | WO2004091493A3 Improved heat shock protein-based vaccines and immunotherapies |
| 04/20/2006 | WO2004044164A3 Method for identifying risk of melanoma and treatments thereof |
| 04/20/2006 | WO2003104401A3 Cancer-linked gene as target for chemotherapy |
| 04/20/2006 | US20060084623 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus |
| 04/20/2006 | US20060084608 Binding polypeptides and methods based thereon |
| 04/20/2006 | US20060084600 Human homologues of fused gene |
| 04/20/2006 | US20060084593 Anti-hiv composition, production method thereof and medicament |
| 04/20/2006 | US20060084148 April-a novel protein with growth effects |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus |
| 04/20/2006 | US20060084107 Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction |
| 04/20/2006 | US20060083758 Treatment of premenstrual disorders |
| 04/20/2006 | US20060083757 Method for treating cardiac muscle disorders |
| 04/20/2006 | US20060083756 Immunogens; replication-defective; antibodies; host cells; kits |
| 04/20/2006 | US20060083755 Vaccine for feline infectious peritonitis |
| 04/20/2006 | US20060083754 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 04/20/2006 | US20060083753 Fusobacterium polypeptides and methods of use |
| 04/20/2006 | US20060083752 Novel compounds |
| 04/20/2006 | US20060083751 Therapeutic agents |
| 04/20/2006 | US20060083750 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| 04/20/2006 | US20060083749 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/20/2006 | US20060083748 Calixarenes for use as excipient for an active substance |
| 04/20/2006 | US20060083747 Fc fusion |
| 04/20/2006 | US20060083746 Receptor for B. anthracis toxin |
| 04/20/2006 | US20060083745 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 04/20/2006 | US20060083744 B7-H1 and methods of diagnosis, prognosis, and treatment of cancer |
| 04/20/2006 | US20060083743 Method of cancer therapy by in situ production of F5 antibodies |
| 04/20/2006 | US20060083742 Prenyl-electrostatic switch, and methods of use |
| 04/20/2006 | US20060083741 Treatment of respiratory syncytial virus (RSV) infection |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083739 Treating prostate cancer with anti-ErbB2 antibodies |
| 04/20/2006 | US20060083738 Treatment of cancer by the use of anti fas antibody |
| 04/20/2006 | US20060083737 Intracellular peptide delivery |
| 04/20/2006 | US20060083736 Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| 04/20/2006 | US20060083735 Antigen-presenting complex-binding compositions and uses thereof |
| 04/20/2006 | US20060083734 Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 04/20/2006 | US20060083716 Composition for delivering an agent to a target cell and uses thereof |
| 04/20/2006 | US20060083714 Combination of a pde iv inhibitor and a tnf-alpha antagonist |
| 04/20/2006 | US20060083686 Therapeutic agent for ulcerative colitis |
| 04/20/2006 | US20060083683 Cysteine residue within the hinge region of the antibody fragment; a disulfide bridge within the hinge region is avoided by substituting another amino acid for the corresponding cysteine residue in the opposite chain of the fragment; conjugate binds the same antigen as the unmodified parental molecule |
| 04/20/2006 | US20060083682 Novel methods of cancer therapy targeted against a cancer stemline |
| 04/20/2006 | DE102004050620A1 Monoklonaler Antikörper gegen Frizzled-Rezeptoren Monoclonal antibodies against Frizzled receptors |
| 04/20/2006 | DE102004050101A1 Recombined polypeptide antibody or antibody fragment binds the ED-B domain of Fibronectin |
| 04/20/2006 | CA2584057A1 Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases |
| 04/20/2006 | CA2583803A1 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 04/20/2006 | CA2583698A1 Refrigerator-temperature stable influenza vaccine compositions |
| 04/20/2006 | CA2583499A1 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
| 04/20/2006 | CA2583257A1 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 04/20/2006 | CA2583230A1 Compositions and methods for treating disease |
| 04/20/2006 | CA2583226A1 Methods and compositions for immunizing against pseudomonas infection |
| 04/20/2006 | CA2583137A1 Therapeutic agents with decreased toxicity |
| 04/20/2006 | CA2583113A1 Compositions comprising an antigen and a promiscuous t-cell epitope |
| 04/20/2006 | CA2583017A1 Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease |
| 04/20/2006 | CA2583011A1 Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy |
| 04/20/2006 | CA2582919A1 Immunotherapy of autoimmune disorders |
| 04/20/2006 | CA2582662A1 Vaccination adjuvants pam3cys, poly(i:c), imiquimod, loxoribine, r-848 and cpg-dna together with mhc i or mhc ii epitopes |
| 04/20/2006 | CA2582455A1 Malaria prime/boost vaccines |
| 04/20/2006 | CA2582228A1 Method for diagnosing and treating crohn's disease |
| 04/20/2006 | CA2582194A1 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | CA2582157A1 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | CA2581355A1 Multivalent avian influenza vaccines |
| 04/20/2006 | CA2580271A1 Method for treating vasculitis |
| 04/20/2006 | CA2577598A1 Modulators of hepatocyte growth factor activator |
| 04/20/2006 | CA2577125A1 Mature dendritic cell compositions and methods for culturing same |